Registry of Atrial Fibrillation and Embolic Risk in Mexico
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belatacept Conversion in Proteinuric Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen
- Status
- WITHDRAWN
- Phase
- PHASE2
Taste Properties of Atazanavir and Cobicistat
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
- Status
- COMPLETED
- Phase
- PHASE2
Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism
- Status
- WITHDRAWN
- Phase
- PHASE4
Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
- Status
- COMPLETED
- Phase
- PHASE4
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive
- Status
- COMPLETED
- Phase
- PHASE2